2 false false false false false false false false false false true false false false false false false No description of principal activity 2025-03-01 Sage Accounts Production Advanced 2025 - FRS102_2025 348,445 450,043 xbrli:pure xbrli:shares iso4217:GBP 13211949 2025-03-01 2026-02-28 13211949 2026-02-28 13211949 2025-02-28 13211949 2024-03-01 2025-02-28 13211949 2025-02-28 13211949 2024-02-29 13211949 bus:RegisteredOffice 2025-03-01 2026-02-28 13211949 bus:Director1 2025-03-01 2026-02-28 13211949 core:WithinOneYear 2026-02-28 13211949 core:WithinOneYear 2025-02-28 13211949 core:RetainedEarningsAccumulatedLosses 2025-03-01 2026-02-28 13211949 core:RetainedEarningsAccumulatedLosses 2024-03-01 2025-02-28 13211949 core:RetainedEarningsAccumulatedLosses 2025-02-28 13211949 core:RetainedEarningsAccumulatedLosses 2024-02-29 13211949 core:RetainedEarningsAccumulatedLosses 2026-02-28 13211949 core:RetainedEarningsAccumulatedLosses 2025-02-28 13211949 core:ShareCapital 2026-02-28 13211949 core:ShareCapital 2025-02-28 13211949 bus:Director1 2025-02-28 13211949 bus:Director1 2025-02-28 13211949 bus:Director1 2024-03-01 2025-02-28 13211949 bus:SmallEntities 2025-03-01 2026-02-28 13211949 bus:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 13211949 bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 13211949 bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 13211949 bus:FullAccounts 2025-03-01 2026-02-28
COMPANY REGISTRATION NUMBER: 13211949
GENERAL PRACTICE CLINIC LIMITED
Unaudited Financial Statements
28 February 2026
GENERAL PRACTICE CLINIC LIMITED
Financial Statements
Year ended 28 February 2026
Contents
Page
Director's report
1
Statement of income and retained earnings
2
Statement of financial position
3
Notes to the financial statements
4
GENERAL PRACTICE CLINIC LIMITED
Director's Report
Year ended 28 February 2026
The director presents her report and the unaudited financial statements of the company for the year ended 28 February 2026 .
Director
The director who served the company during the year was as follows:
Dr H EL-HABTI
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 28 July 2026 and signed on behalf of the board by:
Dr H EL-HABTI
Director
Registered office:
York House
1 Seagrave Road
London
England
SW6 1RP
GENERAL PRACTICE CLINIC LIMITED
Statement of Income and Retained Earnings
Year ended 28 February 2026
2026
2025
Note
£
£
Turnover
1,144,254
1,414,028
Cost of sales
540,903
673,216
------------
------------
Gross profit
603,351
740,812
Administrative expenses
138,757
140,754
---------
---------
Operating profit
464,594
600,058
---------
---------
Profit before taxation
464,594
600,058
Tax on profit
116,149
150,015
---------
---------
Profit for the financial year and total comprehensive income
348,445
450,043
---------
---------
Dividends paid and payable
( 95,890)
( 130,000)
Retained earnings at the start of the year
546,175
226,132
---------
---------
Retained earnings at the end of the year
798,730
546,175
---------
---------
All the activities of the company are from continuing operations.
GENERAL PRACTICE CLINIC LIMITED
Statement of Financial Position
28 February 2026
2026
2025
Note
£
£
Current assets
Debtors
5
–
773
Cash at bank and in hand
922,180
705,368
---------
---------
922,180
706,141
Creditors: amounts falling due within one year
6
123,449
159,965
---------
---------
Net current assets
798,731
546,176
---------
---------
Total assets less current liabilities
798,731
546,176
---------
---------
Net assets
798,731
546,176
---------
---------
Capital and reserves
Called up share capital
1
1
Profit and loss account
798,730
546,175
---------
---------
Shareholders funds
798,731
546,176
---------
---------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 28 July 2026 , and are signed on behalf of the board by:
Dr H EL-HABTI
Director
Company registration number: 13211949
GENERAL PRACTICE CLINIC LIMITED
Notes to the Financial Statements
Year ended 28 February 2026
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is York House, 1 Seagrave Road, London, England, SW6 1RP.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2025: 2 ).
5. Debtors
2026
2025
£
£
Other debtors
–
773
----
----
6. Creditors: amounts falling due within one year
2026
2025
£
£
Corporation tax
116,149
150,015
Other creditors
7,300
9,950
---------
---------
123,449
159,965
---------
---------
7. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2026
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Dr H EL-HABTI
( 4,450)
4,450
–
-------
-------
----
2025
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Dr H EL-HABTI
–
( 4,450)
( 4,450)
----
-------
-------